These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16595559)

  • 21. PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation.
    Liu K; Feng J; Young SS
    J Chem Inf Model; 2005; 45(2):515-22. PubMed ID: 15807517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An empirical process for the design of high-throughput screening deck filters.
    Pearce BC; Sofia MJ; Good AC; Drexler DM; Stock DA
    J Chem Inf Model; 2006; 46(3):1060-8. PubMed ID: 16711725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of a high-throughput screening data set using potency-scaled molecular similarity algorithms.
    Vogt I; Bajorath J
    J Chem Inf Model; 2007; 47(2):367-75. PubMed ID: 17300172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
    Crisman TJ; Jenkins JL; Parker CN; Hill WA; Bender A; Deng Z; Nettles JH; Davies JW; Glick M
    J Biomol Screen; 2007 Apr; 12(3):320-7. PubMed ID: 17438067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of machine-learning and chemometric tools for analysis of in-vivo high-throughput screening data.
    Simmons K; Kinney J; Owens A; Kleier D; Bloch K; Argentar D; Walsh A; Vaidyanathan G
    J Chem Inf Model; 2008 Aug; 48(8):1663-8. PubMed ID: 18681397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Windows .NET Network Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST).
    Dowd SE; Zaragoza J; Rodriguez JR; Oliver MJ; Payton PR
    BMC Bioinformatics; 2005 Apr; 6():93. PubMed ID: 15819992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothesis testing in high-throughput screening for drug discovery.
    Prummer M
    J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic error detection in experimental high-throughput screening.
    Dragiev P; Nadon R; Makarenkov V
    BMC Bioinformatics; 2011 Jan; 12():25. PubMed ID: 21247425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.
    Cloutier LM; Sirois S
    Drug Discov Today; 2008 Jun; 13(11-12):536-42. PubMed ID: 18549981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges of high throughput screening against cell surface receptors.
    Major JS
    J Recept Signal Transduct Res; 1995; 15(1-4):595-607. PubMed ID: 8903966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of high throughput screening in the early stage of drug research].
    Keserü GM
    Acta Pharm Hung; 2004; 74(1):5-10. PubMed ID: 15524043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size determination for the false discovery rate.
    Pounds S; Cheng C
    Bioinformatics; 2005 Dec; 21(23):4263-71. PubMed ID: 16204346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JCell--a Java-based framework for inferring regulatory networks from time series data.
    Spieth C; Supper J; Streichert F; Speer N; Zell A
    Bioinformatics; 2006 Aug; 22(16):2051-2. PubMed ID: 16782725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges facing the biologist doing chemical genetics.
    Soderholm J; Uehara-Bingen M; Weis K; Heald R
    Nat Chem Biol; 2006 Feb; 2(2):55-8. PubMed ID: 16421579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput assays for promiscuous inhibitors.
    Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
    Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.